パテント探偵社 編集部

IP News

Trump Administration Imposes Up to 100 Percent Tariffs on Patented Pharmaceuticals: The IP Implications of Excluding Generics

Up to 100% tariffs on patented drugs, generics exempt. How patent status became the dividing line for U.S. trade policy.
IP News

USPTO Dismisses TikTok’s Patent Challenges, Finding Chinese Government May Be a Real Party in Interest

USPTO vacated seven TikTok IPRs under the Tianma precedent, citing unresolved Chinese government ties as real party in interest.
IP News

EUIPO Report: IP Assets as Collateral — A Roadmap for SME Access to Finance in Europe

The European Union Intellectual Property Office (EUIPO) published a comprehensive report on April 13, 2026, mapping the ...
IP News

CJEU Clarifies Scope of EU Pastiche Copyright Exception in Kraftwerk-Related Sampling Dispute

The Court of Justice of the European Union (CJEU) issued a preliminary ruling on April 14, 2026, clarifying the conditio...
IP News

Federal Circuit Reverses Teva Headache Patent Invalidity, Distinguishing Amgen on §112 Written Description and Enablement

The U.S. Court of Appeals for the Federal Circuit issued a precedential opinion on April 16, 2026, reversing a judgment ...
IP News

USPTO Extends ASAP! AI Pre-Examination Search Pilot Deadline to June 1 Amid Low Participation

The U.S. Patent and Trademark Office (USPTO) announced on April 16, 2026, that it is extending the petition filing deadl...
IP News

No More Display Screens in the Drawings: The Quiet Revolution in Design Patent Law

On March 13, 2026, the United States Patent and Trademark Office (USPTO) published supplemental guidance for the examina...
IP News

Disney Could Have Sued. Instead, It Chose a $1 Billion Handshake with OpenAI

In December 2025, The Walt Disney Company struck a three-year licensing agreement granting OpenAI’s video-generation pla...
IP News

Japan Patent Office Rejects Over 20 Nintendo Monster-Capture Applications Amid Palworld Lawsuit

The Japan Patent Office (JPO) has rejected more than 20 Nintendo Co., Ltd. patent applications directed to monster-captu...
IP News

Federal Circuit Reinstates $177M Teva Verdict Against Eli Lilly in Migraine Drug Patent Dispute

The U.S. Court of Appeals for the Federal Circuit on April 16, 2026 reinstated a $177 million jury verdict in favor of T...